Subsidy Tracker Parent Company Summary

Parent Company Name: 
Mallinckrodt
Ownership Structure: 
publicly traded (ticker symbol MNK)
Headquartered in: 
Ireland
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Subsidy SummarySubsidy ValueNumber of Awards
State/Local$13,711,81321
Federal (grants and allocated tax credits)$4,744,0558
TOTAL$18,455,86829
Loan / Bailout SummaryTotal Face ValueNumber of Awards
State/Local loans, bond financing and venture capital$00
Federal loans, loan guarantees and bailout assistance (not including repayments)$00
TOTAL$00
Time Period for State and Local Awards: 

Earliest year of data: 2000. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2012.

Time Period for Federal Awards: 

FY2000 to the present

Notes: 

Dollar totals do not include awards for which no subsidy value is disclosed.

Associated Names: 

CNS THERAPEUTICS; MALLINCKRODT; STRATATECH; SUCAMPO PHARMA AMERICAS; SUCAMPO PHARMACEUTICALS

Links: 

For a summary of this company's regulatory violations see its Violation Tracker summary page here.


Top 5 States for state/local awardsTotal Subsidy $Number of Awards
New Jersey$10,212,5001
Missouri$2,029,5762
Maryland$907,0528
North Carolina$562,68510

Individual Subsidy Records:

Click on the company name for more information on each subsidy award.
Download results as CSV or XML
Company Location Subsidy Source Year Subsidy Valuesort icon Loan/Bailout Value Type of Subsidy
Mallinckrodt Enterprises, LLC New Jersey state 2016 $10,212,500 tax credit/rebate
STRATATECH CORPORATION United States federal 2016 $2,357,660 federal grant
MALLINCKRODT MEDICAL, INC. Missouri state 2001 $1,274,667 tax credit/rebate
MALLINCKRODT MEDICAL, INC. Missouri state 2000 $754,909 tax credit/rebate
STRATATECH CORPORATION United States federal 2003 $713,812 federal grant
STRATATECH CORPORATION United States federal 2011 $499,877 federal grant
Sucampo Pharmaceuticals, Inc. Maryland state 2016 $450,000 grant/loan hybrid program
Mallinckrodt Enterprises North Carolina state 2012 $441,576 tax credit/rebate
STRATATECH CORPORATION United States federal 2003 $416,559 federal grant
STRATATECH CORPORATION United States federal 2004 $407,329 federal grant
SUCAMPO PHARMACEUTICALS INC Maryland local 2016 $300,000 grant/loan hybrid program
STRATATECH CORPORATION United States federal 2010 $149,383 federal grant
STRATATECH LLC United States federal 2002 $100,000 federal grant
STRATATECH LLC United States federal 2001 $99,435 federal grant
Mallinckrodt Enterprises Holdings, Inc. North Carolina state 2015 $55,013 tax credit/rebate
Sucampo Pharmaceuticals, Inc. Maryland state 2004 $50,128 tax credit/rebate
Sucampo Pharma Americas, Inc. Maryland state 2011 $37,575 tax credit/rebate
Sucampo Pharmaceuticals, Inc. Maryland state 2007 $31,263 tax credit/rebate
Mallinckrodt Enterprises Holdings, Inc. North Carolina state 2015 $24,415 tax credit/rebate
Sucampo Pharma Americas, Inc. Maryland state 2009 $17,600 tax credit/rebate
Sucampo Pharma Americas, Inc. Maryland state 2010 $15,746 tax credit/rebate
Mallinckrodt Enterprises Holdings, Inc. North Carolina state 2016 $10,587 tax credit/rebate
Mallinckrodt, Inc. (DE) North Carolina state 2011 $8,686 tax credit/rebate
Mallinckrodt Enterprises Holdings, Inc. North Carolina state 2015 $6,404 tax credit/rebate
Mallinckrodt Enterprises Holdings, Inc. North Carolina state 2013 $6,107 tax credit/rebate
Sucampo Pharmaceuticals, Inc. Maryland state 2016 $4,740 tax credit/rebate
Mallinckrodt Enterprises Holdings, Inc. North Carolina state 2012 $3,891 tax credit/rebate
Mallinckrodt Enterprises Holdings, Inc. North Carolina state 2012 $3,891 tax credit/rebate
CNS Therapeutics, Inc. North Carolina state 2015 $2,115 tax credit/rebate
Mallinckrodt LLC Missouri local 2008 undisclosed loan or bond financing
Download results as CSV or XML